Life Biosciences

Altos Labs

This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.

Cirrus Therapeutics

This company develops gene and cell therapies to treat age-related macular degeneration and chronic vision loss for patients with blinding eye diseases.

CIRC Biosciences

This cell therapy company develops chemically induced retinal cells to restore vision for patients with macular degeneration and retinitis pigmentosa.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

clock.bio

This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.

Rejuveron Life Sciences

This clinical-stage biotechnology company develops regenerative medicines and small-molecule therapies for patients with age-related diseases to improve healthspan and longevity.

Restore Vision

This clinical-stage biotechnology company develops visual restoration gene therapies to treat blindness caused by genetic retinal disorders for patients with retinitis pigmentosa.

Souvien Therapeutics

This biotechnology company develops therapeutic agents targeting epigenetic mechanisms to treat neurodegenerative diseases for patients with age-related conditions like dementia.